Cosmos Health (COSM) holder reports 4.14M shares, 8.15% stake in amendment

Rhea-AI Filing Summary

Cosmos Health Inc. filed an amendment to Schedule 13G/A reporting beneficial ownership of 4,143,007.21 shares of Common Stock, representing 8.152% of the class. The filing states this percentage is based on approximately 50,824,657 shares outstanding as of April 14, 2026. The report lists Andreas Bovopoulos as the beneficial owner with sole voting and dispositive power over the reported shares.

Insights

Institutional Ownership Analyst

Large passive holder disclosure: single beneficial owner at ~8.15% of outstanding shares.

The amendment records 4,143,007.21 shares beneficially owned by Andreas Bovopoulos with sole voting and dispositive power. The filing clarifies ownership percentage using an outstanding share figure of 50,824,657 as of April 14, 2026.

Holder decisions determine future activity; subsequent Schedule 13 filings would disclose any material changes in stake or voting arrangements.

Securities Compliance Specialist

Amendment aligns beneficial ownership reporting with Schedule 13G/A mechanics.

The form indicates an ownership update rather than a transaction: it reports sole voting and dispositive powers for the named individual. The filing is procedural, documenting a passive/beneficial stake at the stated percentage.

Regulatory watchers would note the precise share and percent figures for record-keeping and any future Section 13(d) thresholds.

Key Figures

Beneficially owned shares: 4,143,007.21 shares Percent of class: 8.152% Shares outstanding used: 50,824,657 shares

3 metrics

Beneficially owned shares 4,143,007.21 shares Amount reported as beneficially owned by Andreas Bovopoulos

Percent of class 8.152% Ownership percentage based on outstanding shares as of April 14, 2026

Shares outstanding used 50,824,657 shares Approximate outstanding common shares as of April 14, 2026 (basis for percentage)

Key Terms

Schedule 13G/A, beneficially owned, sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 3 to Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 4,143,007.21"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole Dispositive Power 4,143,007.21"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 08:33 PM Learn about SEC filing dates

FAQ

What stake does Andreas Bovopoulos report in COSM?

He reports beneficial ownership of 4,143,007.21 shares, representing 8.152% of the class. The filing bases this percentage on approximately 50,824,657 shares outstanding as of April 14, 2026, and shows sole voting and dispositive power.

Does the Schedule 13G/A amendment show voting control for COSM shares?

Yes — the filing lists sole voting power and sole dispositive power over 4,143,007.21 shares. It reports no shared voting or dispositive power for the reported position.

What date is the outstanding share count based on in the COSM filing?

The percentage calculation cites an outstanding share figure of 50,824,657 as of April 14, 2026. That figure is used to compute the 8.152% ownership percentage reported.

Does this Schedule 13G/A amendment indicate a purchase or sale?

No — the amendment reports beneficial ownership and control attributes; it does not state a specific purchase or sale. It documents the holder's position and voting/dispositive powers as reported on the form.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Cosmos Health Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

221413206

(CUSIP Number)

04/24/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 221413206

1

Names of Reporting Persons

Bovopoulos Andreas

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,143,007.21
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,143,007.21
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,143,007.21

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.2 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Percentage based on approximately 50,824,657 shares of common stock outstanding as of April 14, 2026, based on publicly available information. Based on this number, the percentage of class represented is approximately 8.152%

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cosmos Health Inc.
(b)	Address of issuer's principal executive offices: 5 AGIOU GEORGIOU, PILEA, THESSALONIKI, GREECE, 55438
Item 2.
(a)	Name of person filing: Andreas Bovopoulos
(b)	Address or principal business office or, if none, residence: 15413 Lone Hill Road Los Gatos, CA 95032
(c)	Citizenship: USA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 221413206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,143,007.21
(b)	Percent of class: 8.152%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,143,007.21
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4,143,007.21
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bovopoulos Andreas

Signature:	Andreas Bovopoulos
Name/Title:	Individual Investor
Date:	04/24/2026